search
Back to results

Effectiveness of Core-Needle US Guided Biopsy as Primary Tool For Diagnosis of Thyroid Nodules

Primary Purpose

Thyroid Nodule, Thyroid Diseases, Thyroid Gland; Node

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
FNB
Core biopsy
Sponsored by
Kafrelsheikh University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Thyroid Nodule focused on measuring Thyroid nodule, Core needle biopsy, FNB

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • patients with nodules larger than 1 cm in diameter and suspicious ultrasound criteria with TIRADS category III or higher.

Exclusion Criteria:

  • Patients with a history of hemodynamic instability or inadequate coagulation profile were excluded

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Active Comparator

    Arm Label

    FNB

    Core biopsy

    Arm Description

    Outcomes

    Primary Outcome Measures

    Number of samples in FNB and CNB matching the final pathology
    Comparing number of samples in FNB and CNB that make same diagnosis as the final postoperative pathology

    Secondary Outcome Measures

    Full Information

    First Posted
    February 9, 2021
    Last Updated
    February 16, 2021
    Sponsor
    Kafrelsheikh University
    Collaborators
    Alexandria University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04759053
    Brief Title
    Effectiveness of Core-Needle US Guided Biopsy as Primary Tool For Diagnosis of Thyroid Nodules
    Official Title
    Effectiveness of Core-Needle US Guided Biopsy as Primary Tool For Diagnosis of Thyroid Nodules, A Prospective Study
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    February 2021
    Overall Recruitment Status
    Completed
    Study Start Date
    January 1, 2017 (Actual)
    Primary Completion Date
    January 1, 2018 (Actual)
    Study Completion Date
    February 1, 2018 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Kafrelsheikh University
    Collaborators
    Alexandria University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The study aimed to determine the best intervention between Core biopsy and Fine needle aspiration in diagnosis of thyroid malignancy.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Thyroid Nodule, Thyroid Diseases, Thyroid Gland; Node
    Keywords
    Thyroid nodule, Core needle biopsy, FNB

    7. Study Design

    Primary Purpose
    Diagnostic
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    Participant
    Allocation
    Randomized
    Enrollment
    60 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    FNB
    Arm Type
    Active Comparator
    Arm Title
    Core biopsy
    Arm Type
    Active Comparator
    Intervention Type
    Procedure
    Intervention Name(s)
    FNB
    Intervention Description
    Fine needle aspiration from the nodules
    Intervention Type
    Procedure
    Intervention Name(s)
    Core biopsy
    Intervention Description
    Core biopsy from thyroid nodules
    Primary Outcome Measure Information:
    Title
    Number of samples in FNB and CNB matching the final pathology
    Description
    Comparing number of samples in FNB and CNB that make same diagnosis as the final postoperative pathology
    Time Frame
    7 days

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    65 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: patients with nodules larger than 1 cm in diameter and suspicious ultrasound criteria with TIRADS category III or higher. Exclusion Criteria: Patients with a history of hemodynamic instability or inadequate coagulation profile were excluded

    12. IPD Sharing Statement

    Learn more about this trial

    Effectiveness of Core-Needle US Guided Biopsy as Primary Tool For Diagnosis of Thyroid Nodules

    We'll reach out to this number within 24 hrs